EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence of Neurodevelopmental Disorders in Families of Women Taking Psychotropic Medication During Pregnancy

Akhila Srinivas Reddy iD, Marleen M H J van Gelder iD, Emilie Willoch Olstad iD, Kristina Gervin iD, Janne von Koss Torkildsen, Hedvig Nordeng iD

Paediatric and Perinatal Epidemiology · 2026

DOI: 10.1111/ppe.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatric and Perinatal Epidemiology, 2026. Verfasst von Akhila Srinivas Reddy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Psychotropic Drugs, Prenatal Exposure Delayed Effects, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Livsvitenskap, Universitetet i Oslo, Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Familial and environmental factors contribute to neurodevelopmental disorders (NDDs). Prenatal psychotropic exposure may influence the risk of NDDs in children. As these medications are prescribed to women with mental disorders, which are genetically and environmentally linked to NDDs, accounting for familial confounding is essential when studying medication safety in pregnancy.

Objectives

To compare the prevalence of NDDs in pregnant women using psychotropics, their partners, and their previous children, with those not using these medications.

Methods

We included data from the most recent pregnancy of Norwegian women with mental disorders who gave birth between 2010 and 2018, using Norwegian registries. Maternal psychotropic use included antidepressants, antipsychotics, anxiolytics, hypnotics, and sedatives, as recorded in the Norwegian Prescription Database. NDDs were identified using ICD‐10 codes for intellectual disabilities, language/scholastic disorders, pervasive developmental disorders, and attention‐deficit hyperactivity disorders (ADHD) from the Norwegian Patient Registry. Modified Poisson regression estimated crude and adjusted relative risks (aRRs) for the association between psychotropic use and family history of NDDs.

Results

The study included 27,638 women. Among psychotropic users, NDDs prevalence was 9.6% in women, 5.4% in partners, and 10.0% in previous children, compared to 5.7%, 4.6%, and 8.0% in non‐users, respectively. ADHD was the most prevalent NDD. Psychotropic use in pregnancy was associated with any NDD, particularly ADHD, in the women [any NDD aRR 1.77 (95% CI 1.60, 1.95); ADHD aRR 1.79 (95% CI 1.61, 1.98)], previous children [any NDD aRR 1.25 (95% CI 1.07, 1.47); ADHD aRR 1.26 (95% CI 1.02, 1.54)], and partners [any NDD aRR 1.21 (95% CI 1.06, 1.37); ADHD aRR 1.22 (95% CI 1.07, 1.39)].

Conclusions

Prenatal psychotropic use was associated with a higher prevalence of NDDs in mothers and their previous children, highlighting the need to account for familial neurodevelopmental patterns to distinguish the effects of psychotropics from underlying genetic or familial factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodevelopmental DisordersPsychotropic DrugsPrenatal Exposure Delayed EffectsPregnancy ComplicationsMental DisordersHumansFemalePregnancyNorwayPrevalenceAdultRegistriesYoung AdultAdolescent

Stichwörter der Autor:innen

attention deficit hyperactivity disorderfamilial neurodevelopmental disordersmental health disordersneurodevelopmental disordersprenatal psychotropic use

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • UiO:RealArt Convergence Environment, University of Oslo, Oslo, Norway.
  • IQ Health Science Department, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
  • Department of Special Needs Education, University of Oslo, Oslo, Norway.
  • Centre for Research on Equality in Education, University of Oslo, Oslo, Norway.

ORCID-Profile: Akhila Srinivas Reddy, Marleen M H J van Gelder, Emilie Willoch Olstad, Kristina Gervin, Hedvig Nordeng

Förderung

  • Livsvitenskap, Universitetet i Oslo
  • Norges Forskningsråd

Zitieren

APA

Reddy, A. S., van Gelder, M. M. H. J., Olstad, E. W., Gervin, K., von Koss Torkildsen, J., & Nordeng, H. (2026). Prevalence of Neurodevelopmental Disorders in Families of Women Taking Psychotropic Medication During Pregnancy. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.70075

Vancouver

Reddy AS, van Gelder MMHJ, Olstad EW, Gervin K, von Koss Torkildsen J, Nordeng H. Prevalence of Neurodevelopmental Disorders in Families of Women Taking Psychotropic Medication During Pregnancy. Paediatric and Perinatal Epidemiology. 2026. doi:10.1111/ppe.70075

BibTeX
@article{Reddy2026,
  author = {Reddy, Akhila Srinivas and van Gelder, Marleen M H J and Olstad, Emilie Willoch and Gervin, Kristina and von Koss Torkildsen, Janne and Nordeng, Hedvig},
  title = {Prevalence of Neurodevelopmental Disorders in Families of Women Taking Psychotropic Medication During Pregnancy},
  journal = {Paediatric and Perinatal Epidemiology},
  year = {2026},
  doi = {10.1111/ppe.70075}
}
Kostenlos starten →